Spectral Diagnostics Inc (DIAGF.PK)

DIAGF.PK on OTC Markets Group

0.27USD
18 Dec 2014
Price Change (% chg)

$0.04 (+15.40%)
Prev Close
$0.27
Open
$0.31
Day's High
$0.31
Day's Low
$0.30
Volume
42,903
Avg. Vol
16,947
52-wk High
$0.61
52-wk Low
$0.21

DIAGF.PK

Chart for DIAGF.PK

About

Spectral Diagnostics Inc. (Spectral) is focuses on the development and commercialization of a treatment for severe sepsis. The Company’s products include Endotoxin Activity Assay (EAA) and the Toraymyxin therapeutic (PMX) and Reagents. The Company also manufactures and sells certain proprietary reagents. Endotoxin Activity Assay... (more)

Overall

Beta: 2.14
Market Cap (Mil.): $52.80
Shares Outstanding (Mil.): 179.74
Dividend: --
Yield (%): --

Financials

  DIAGF.PK Industry Sector
P/E (TTM): -- 34.98 38.47
EPS (TTM): -0.07 -- --
ROI: -113.51 10.78 18.25
ROE: -113.51 12.60 19.13
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks